{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:25:41Z","timestamp":1779377141725,"version":"3.53.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejca.2022.07.021","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T18:09:36Z","timestamp":1660932576000},"page":"142-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1272-532X","authenticated-orcid":false,"given":"Jan","family":"Franko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-9664","authenticated-orcid":false,"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-7243","authenticated-orcid":false,"given":"Richard A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zalcberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Fiskum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Van Cutsem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0308-8223","authenticated-orcid":false,"given":"Richard M.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fairooz","family":"Kabbinavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1279-2044","authenticated-orcid":false,"given":"Benoist","family":"Chibaudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimery","family":"de Gramont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.07.021_bib1","volume":"vol. 3","year":"2021"},{"key":"10.1016\/j.ejca.2022.07.021_bib2","article-title":"Detection of molecular residual disease using personalized circulating tumor DNA assay in patients with colorectal cancer undergoing resection of metastases","volume":"5","author":"Loupakis","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2022.07.021_bib4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/cncr.27938","article-title":"Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy","volume":"119","author":"Sinicrope","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.07.021_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa024","article-title":"Body mass index and weight loss in metastatic colorectal cancer in CALGB (alliance)\/SWOG 80405","volume":"4","author":"Guercio","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.ejca.2022.07.021_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/s0004-2803.202000000-24","article-title":"Clinical evaluation and pattern of symptoms in colorectal cancer patients","volume":"57","author":"Mello","year":"2020","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.ejca.2022.07.021_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1055-9965.EPI-16-0145","article-title":"Association of weight change after colorectal cancer diagnosis and outcomes in the kaiser permanente northern California population","volume":"26","author":"Meyerhardt","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2022.07.021_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.2015.61.6441","article-title":"Body mass index is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD database","volume":"34","author":"Renfro","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s12032-011-9894-z","article-title":"A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab","volume":"29","author":"Poterucha","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3389\/fonc.2018.00620","article-title":"Body mass index and long-term outcomes in patients with colorectal cancer","volume":"8","author":"Shahjehan","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib11","first-page":"16","article-title":"Impact of weight changes after the diagnosis of stage III colon cancer on survival outcomes","volume":"15","author":"Vergidis","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejca.2022.07.021_bib12","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1002\/cncr.30932","article-title":"Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: the Colon Cancer Family Registry","volume":"123","author":"Kocarnik","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.07.021_bib13","first-page":"533","article-title":"Prognostic significance of unintentional body weight loss in colon cancer patients","volume":"8","author":"Kuo","year":"2018","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib14","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1200\/JCO.2016.71.5771","article-title":"Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: an Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancerologie Digestive Database","volume":"35","author":"Renfro","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib15","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/cncr.28072","article-title":"Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer","volume":"119","author":"Innominato","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.07.021_bib16","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib17","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/ajcn\/nqz209","article-title":"Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients","volume":"110","author":"Kurk","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejca.2022.07.021_bib18","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.07.021_bib19","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1200\/JCO.2005.00.232","article-title":"Combined analysis of efficacy: the addition of bevacizumab to fluorouracil\/leucovorin improves survival for patients with metastatic colorectal cancer","volume":"23","author":"Kabbinavar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.07.021_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"22","author":"Goldberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1200\/JCO.2008.20.8397","article-title":"Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer","volume":"27","author":"Bokemeyer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/annonc\/mdr547","article-title":"The ARCAD advanced colorectal cancer database--open for business","volume":"23","author":"Buyse","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1017\/S0007114512002073","article-title":"Gastrointestinal symptoms and weight loss in cancer patients receiving chemotherapy","volume":"109","author":"Sanchez-Lara","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ejca.2022.07.021_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/annonc\/mdf034","article-title":"Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients","volume":"13","author":"K\u00f6hne","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ijc.33775","article-title":"Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)","volume":"150","author":"Liu","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2022.07.021_bib28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaoncol.2021.0884","article-title":"Association of cancer screening deficit in the United States with the COVID-19 pandemic","volume":"7","author":"Chen","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36809","article-title":"Association of long-term trajectories of neighborhood socioeconomic status with weight change in older adults","volume":"4","author":"Zhang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejca.2022.07.021_bib30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","article-title":"Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer","volume":"34","author":"Blauwhoff-Buskermolen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib31","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3945\/ajcn.113.060228","article-title":"Central tenet of cancer\u00a0cachexia therapy: do patients with advanced cancer have\u00a0exploitable anabolic potential?","volume":"98","author":"Prado","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejca.2022.07.021_bib32","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1200\/JCO.2005.04.4792","article-title":"Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line","volume":"23","author":"Grothey","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1186\/s12885-019-6086-2","article-title":"No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer","volume":"19","author":"Antoun","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2022.07.021_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejca.2022.07.021_bib35","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0101","article-title":"The concept of \u201cObstruction-Free Survival\u201d as an outcome measure in advanced colorectal cancer management","volume":"3","author":"Moran","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejca.2022.07.021_bib36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1200\/JCO.2018.36.4_suppl.850","article-title":"Body weight and composition changes, primary tumor side, and resection as survival predictors in metastatic colorectal cancer","volume":"36","author":"Franko","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib37","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s10434-001-0632-1","article-title":"Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer","volume":"8","author":"Blair","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.07.021_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.07.021_bib39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","article-title":"ESPEN expert group recommendations for action against cancer-related malnutrition","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ejca.2022.07.021_bib40","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ejca.2022.07.021_bib41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/01635581.2018.1504092","article-title":"Cancer cachexia: identification by clinical assessment versus international consensus criteria in patients with metastatic colorectal cancer","volume":"70","author":"van der Werf","year":"2018","journal-title":"Nutr Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922004452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922004452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:37:17Z","timestamp":1760733437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922004452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":41,"alternative-id":["S0959804922004452"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.07.021","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}